Supernus Pharmaceuticals | Betriebsaufwand



Operating Expenses Veränderung Datum
Abbott USD 8.7B 363M 2025-03
ANI Pharmaceuticals USD 194.95M 211M 2024-12
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bristol-Myers Squibb USD 8.23B 3.32B 2025-03
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 156.63M 20.68M 2024-12
Eisai JPY 188.58B 7.01B 2024-12
Eli Lilly USD 7.32B 1.06B 2025-03
Indivior 200M 193M 2025-03
Novo Nordisk 37.49B 4.64B 2024-09
Pacira USD 162.55M 145.55M 2024-12
Perrigo USD 1.03B 13.4M 2024-12
Pfizer USD 10.05B 8.12B 2025-03
Supernus Pharmaceuticals USD 152.75M 17.91M 2024-12
United Therapeutics USD 411.6M 33.4M 2025-03
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12



Supernus Pharmaceuticals Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.